| Sign In to gain access to subscriptions and/or personal tools. |
Transforming growth factor beta 1 in children with systemic lupus erythematosus: a possible relation with clinical presentation of lupus nephritisDepartment of Pediatrics, Mansoura Faculty of Medicine, Egypt
Department of Rheumatology & Rehabilitation, Mansoura Faculty of Medicine, Egypt, hazemyoussef{at}nhs.net
Department of Clinical Pathology, Mansoura Faculty of Medicine, Egypt Plasma and urinary (latent and active) TGF-ß1 levels were assessed in 32 children with active lupus and compared to 15 healthy controls of matched age and sex. Plasma latent and active TGF-ß1 levels in children with active disease were significantly lower than controls (P = 0.004 and P < 0.001 respectively). Plasma active TGF-ß1 correlated negatively with Systemic Lupus Erythematosus Disease Activity Index (r =-0.38, P = 0.03). On the contrary, urinary latent and active TGF-ß1 levels in children with active disease were significantly higher than controls (P < 0.001 and P = 0.003 respectively). Urinary active TGF-ß1 levels correlated positively with Anti-ds DNA titre (r = 0.42, P = 0.015) and negatively with serum C3 levels (r =-0.48, P = 0.005). Patients with symptomatic nephritis had significantly elevated urinary active TGF-ß1 levels in comparison to those with silent nephritis (P = 0.008). From this data we conclude that lowered plasma TGF-ß1 levels may be a feature of systemic immune dysfunction in children with active lupus while increased renal production of active TGF-ß1 seems to have a role in the clinical presentation of lupus nephritis.
Key Words: children nephritis SLE TGF-ß1
Lupus, Vol. 15, No. 9,
608-612 (2006) This article has been cited by other articles:
|
|||||||||||||||
